BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20737467)

  • 1. Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis.
    Happonen KE; Saxne T; Aspberg A; Mörgelin M; Heinegård D; Blom AM
    Arthritis Rheum; 2010 Dec; 62(12):3574-83. PubMed ID: 20737467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
    Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
    Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation.
    Neidhart M; Hauser N; Paulsson M; DiCesare PE; Michel BA; Häuselmann HJ
    Br J Rheumatol; 1997 Nov; 36(11):1151-60. PubMed ID: 9402858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISA.
    Lai Y; Yu XP; Zhang Y; Tian Q; Song H; Mucignat MT; Perris R; Samuels J; Krasnokutsky S; Attur M; Greenberg JD; Abramson SB; Di Cesare PE; Liu CJ
    Osteoarthritis Cartilage; 2012 Aug; 20(8):854-62. PubMed ID: 22595227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment.
    Happonen KE; Saxne T; Geborek P; Andersson M; Bengtsson AA; Hesselstrand R; Heinegård D; Blom AM
    Arthritis Res Ther; 2012 Jan; 14(1):R15. PubMed ID: 22264230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMP-C3b complexes in rheumatoid arthritis with severe extraarticular manifestations.
    Happonen KE; Saxne T; Jacobsson L; Sturfelt G; Rönnelid J; Mollnes TE; Heinegård D; Turesson C; Blom AM
    J Rheumatol; 2013 Dec; 40(12):2001-5. PubMed ID: 24187101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assays.
    Lorenzo P; Aspberg A; Saxne T; Önnerfjord P
    Osteoarthritis Cartilage; 2017 Sep; 25(9):1436-1442. PubMed ID: 28473207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cartilage oligomeric matrix protein forms protein complexes with synovial lubricin via non-covalent and covalent interactions.
    Flowers SA; Kalamajski S; Ali L; Björkman LI; Raj JR; Aspberg A; Karlsson NG; Jin C
    Osteoarthritis Cartilage; 2017 Sep; 25(9):1496-1504. PubMed ID: 28373131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts.
    Dodge GR; Hawkins D; Boesler E; Sakai L; Jimenez SA
    Osteoarthritis Cartilage; 1998 Nov; 6(6):435-40. PubMed ID: 10343777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
    Wisłowska M; Jabłońska B
    Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.
    Mânsson B; Gülfe A; Geborek P; Heinegård D; Saxne T
    Ann Rheum Dis; 2001 Jan; 60(1):27-31. PubMed ID: 11114278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease.
    Arai K; Misumi K; Carter SD; Shinbara S; Fujiki M; Sakamoto H
    Equine Vet J; 2005 Jan; 37(1):31-6. PubMed ID: 15651731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein.
    Guo F; Lai Y; Tian Q; Lin EA; Kong L; Liu C
    Arthritis Rheum; 2010 Jul; 62(7):2023-36. PubMed ID: 20506400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids.
    Hummel KM; Neidhart M; Vilim V; Hauser N; Aicher WK; Gay RE; Gay S; Häuselmann HJ
    Br J Rheumatol; 1998 Jul; 37(7):721-8. PubMed ID: 9714346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid.
    Ganu V; Goldberg R; Peppard J; Rediske J; Melton R; Hu SI; Wang W; Duvander C; Heinegård D
    Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs.
    Dickinson SC; Vankemmelbeke MN; Buttle DJ; Rosenberg K; Heinegård D; Hollander AP
    Matrix Biol; 2003 May; 22(3):267-78. PubMed ID: 12853037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of lectin pathway proteins in plasma and synovial fluid of rheumatoid arthritis and osteoarthritis.
    Ammitzboll CG; Thiel S; Ellingsen T; Deleuran B; Jorgensen A; Jensenius JC; Stengaard-Pedersen K
    Rheumatol Int; 2012 May; 32(5):1457-63. PubMed ID: 21461857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood.
    Saxne T; Heinegård D
    Br J Rheumatol; 1992 Sep; 31(9):583-91. PubMed ID: 1381980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids.
    Vilim V; Lenz ME; Vytasek R; Masuda K; Pavelka K; Kuettner KE; Thonar EJ
    Arch Biochem Biophys; 1997 May; 341(1):8-16. PubMed ID: 9143347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis.
    Otteby KE; Holmquist E; Saxne T; Heinegård D; Hesselstrand R; Blom AM
    Arthritis Res Ther; 2013; 15(6):R215. PubMed ID: 24330664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.